Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of MEX3B mRNA | CTD | PMID:28960355 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of MEX3B mRNA | CTD | PMID:22574217 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MEX3B mRNA | CTD | PMID:31614463 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of MEX3B mRNA | CTD | PMID:30165855 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Mex3b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Mex3b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MEX3B mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MEX3B mRNA | CTD | PMID:21215274 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mex3b (Rattus norvegicus) | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of MEX3B mRNA] | CTD | PMID:21215274 | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of MEX3B mRNA | CTD | PMID:37199045 | 3,4-dichloroaniline | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | 3 and 4-dichloroaniline results in increased expression of MEX3B mRNA | CTD | PMID:24172598 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Mex3b (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of MEX3B exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Mex3b (Mus musculus) | 6480464 | bisphenol S affects the methylation of MEX3B gene | CTD | PMID:31683443 | 6-propyl-2-thiouracil | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of MEX3B mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | acetamide results in increased expression of MEX3B mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MEX3B mRNA | CTD | PMID:22100608 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of MEX3B mRNA | CTD | PMID:23724009 and PMID:23830798 | amphetamine | decreases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of MEX3B mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of MEX3B mRNA | CTD | PMID:24449571 | azoxystrobin | decreases expression | EXP | | 6480464 | azoxystrobin results in decreased expression of MEX3B mRNA | CTD | PMID:33512557 | benzo[a]pyrene | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MEX3B mRNA | CTD | PMID:21569818 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MEX3B mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | Mex3b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of MEX3B 3' UTR and Benzo(a)pyrene results in decreased methylation of MEX3B exon | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of MEX3B mRNA | CTD | PMID:31163220 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of MEX3B mRNA | CTD | PMID:35716406 | bisphenol A | decreases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MEX3B mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of MEX3B gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MEX3B mRNA | CTD | PMID:33296240 and PMID:34947998 | bisphenol A | increases expression | ISO | Mex3b (Mus musculus) | 6480464 | bisphenol A results in increased expression of MEX3B mRNA | CTD | PMID:25594700 | bromobenzene | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | bromobenzene results in increased expression of MEX3B mRNA | CTD | PMID:32479839 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MEX3B gene] | CTD | PMID:28238834 | chloroprene | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | Chloroprene results in decreased expression of MEX3B mRNA | CTD | PMID:23125180 | cisplatin | decreases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Cisplatin results in decreased expression of MEX3B mRNA | CTD | PMID:22023808 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of MEX3B mRNA | CTD | PMID:27594783 | copper atom | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Copper results in increased expression of MEX3B mRNA | CTD | PMID:30556269 | copper(0) | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Copper results in increased expression of MEX3B mRNA | CTD | PMID:30556269 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of MEX3B mRNA | CTD | PMID:19549813 | decabromodiphenyl ether | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in increased expression of MEX3B mRNA | CTD | PMID:23640034 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of MEX3B gene | CTD | PMID:22964155 | dibutyl phthalate | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of MEX3B mRNA | CTD | PMID:21266533 | dimethylselenide | multiple interactions | EXP | | 6480464 | [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA and [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA | CTD | PMID:33656867 | dioxygen | multiple interactions | ISO | Mex3b (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEX3B mRNA | CTD | PMID:30529165 | diuron | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Diuron metabolite results in increased expression of MEX3B mRNA | CTD | PMID:24172598 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of MEX3B mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of MEX3B mRNA | CTD | PMID:26615145 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of MEX3B mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA | CTD | PMID:27188386 | folic acid | increases expression | ISO | Mex3b (Mus musculus) | 6480464 | Folic Acid results in increased expression of MEX3B mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of MEX3B mRNA | CTD | PMID:23416264 and PMID:23649840 | gentamycin | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of MEX3B mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MEX3B mRNA | CTD | PMID:33387578 | glyphosate | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | Glyphosate results in decreased expression of MEX3B mRNA | CTD | PMID:35897073 | kenpaullone | decreases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | kenpaullone results in decreased expression of MEX3B mRNA | CTD | PMID:17993264 | kojic acid | increases expression | EXP | | 6480464 | kojic acid results in increased expression of MEX3B mRNA | CTD | PMID:16595896 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of MEX3B mRNA | CTD | PMID:28988120 | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of MEX3B mRNA | CTD | PMID:33647349 | lithium chloride | decreases expression | EXP | | 6480464 | Lithium Chloride results in decreased expression of MEX3B mRNA | CTD | PMID:23527032 | melphalan | increases expression | EXP | | 6480464 | Melphalan results in increased expression of MEX3B mRNA | CTD | PMID:22363485 | methotrexate | affects expression | ISO | Mex3b (Mus musculus) | 6480464 | Methotrexate affects the expression of MEX3B mRNA | CTD | PMID:18502557 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of MEX3B mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of MEX3B mRNA | CTD | PMID:26272509 | methylmercury chloride | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEX3B mRNA | CTD | PMID:27188386 | N-Nitrosopyrrolidine | increases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in increased expression of MEX3B mRNA | CTD | PMID:32234424 | nickel dichloride | affects expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | nickel chloride affects the expression of MEX3B mRNA | CTD | PMID:22110744 | orphenadrine | affects expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Orphenadrine affects the expression of MEX3B mRNA | CTD | PMID:23665939 | ozone | multiple interactions | ISO | Mex3b (Mus musculus) | 6480464 | [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in decreased expression of MEX3B mRNA | CTD | PMID:25658374 | paracetamol | affects expression | ISO | Mex3b (Mus musculus) | 6480464 | Acetaminophen affects the expression of MEX3B mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of MEX3B mRNA | CTD | PMID:33387578 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MEX3B mRNA | CTD | PMID:29067470 | paraquat | decreases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of MEX3B mRNA | CTD | PMID:32680482 | PCB138 | multiple interactions | ISO | Mex3b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of MEX3B mRNA | CTD | PMID:19159669 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of MEX3B mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA | CTD | PMID:27188386 | picoxystrobin | decreases expression | EXP | | 6480464 | picoxystrobin results in decreased expression of MEX3B mRNA | CTD | PMID:33512557 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Mex3b (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of MEX3B mRNA | CTD | PMID:22698814 | reactive oxygen species | multiple interactions | EXP | | 6480464 | [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA and [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA | CTD | PMID:33656867 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of MEX3B mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | Silver results in decreased expression of MEX3B mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Mex3b (Mus musculus) | 6480464 | Silver results in decreased expression of MEX3B mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MEX3B mRNA | CTD | PMID:21457566 | sodium dichromate | affects expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | sodium bichromate affects the expression of MEX3B mRNA | CTD | PMID:22110744 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of MEX3B mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | ISO | Mex3b (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of MEX3B mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of MEX3B mRNA | CTD | PMID:34973136 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of MEX3B mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA | CTD | PMID:27188386 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of MEX3B mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MEX3B mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MEX3B mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA | CTD | PMID:27188386 | |